ADAR Antikörper
Kurzübersicht für ADAR Antikörper (ABIN5699808)
Target
Alle ADAR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Immunogen
- adenosine deaminase, RNA-specific
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB :1:500-1:5000,IHC:1:20-1:200,IP:1:200-1:2000,IF:1:20-1:200
-
Kommentare
-
HeLa cells were subjected to SDS PAGE followed by western blot with FNab00150( ADAR1 Antibody) at dilution of 1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Haltbarkeit
- 12 months
-
-
- ADAR (Adenosine Deaminase, RNA-Specific (ADAR))
-
Andere Bezeichnung
- ADAR1
-
Hintergrund
- Synonyms:ADAR, ADAR1, adenosine deaminase, RNA, DRADA, DSH, DSRAD, G1P1, IFI 4, IFI4, Interferon inducible protein 4, K88dsRBP, p136 Background:ADAR1 is also named as ADAR1, DSRAD, G1P1, IFI4. It convert selected adenosine residues into inosine in substrate RNAs containing a relatively short dsRNA region(PMID:15556947). The human ADAR1 gene specifies two size forms of RNA-specific adenosine deaminase, an interferon(IFN) inducible ?150 kDa protein and a constitutively expressed N-terminally truncated ?110 kDa protein, encoded by transcripts with alternative exon 1 structures that initiate from different promoters(PMID:11111054). It has 5 isoforms produced by alternative promoter usage and alternative splicing. Defects in ADAR are a cause of dyschromatosis symmetrical hereditaria(DSH).ADAR1 can form respective homodimers, and this association is essential for its enzymatic activities(PMID:17428802).
-
Molekulargewicht
- 136kDa,observed 110kDa
-
UniProt
- P55265
-
Pathways
- Protein targeting to Nucleus
Target
-